Article Information
History
- January 7, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Yoona Lee1,
- Rebecca Freitag1,
- Rajkumar Ganesan2,
- Veit Schwämmle1,
- Sandeep Kumar3 and
- Konrad Krawczyk1,*
- 1University of Southern Denmark, Odense, Denmark
- 2Oncology Research, Amgen, South San Francisco, CA, USA
- 3Biotherapeutics Discovery, Boehringer Ingelheim Pharmaceuticals Inc, Ridgefield, CT, USA
- ↵*Author for correspondence: konrad{at}sciride.org
Posted January 07, 2023.
